Bridge Pharmaceuticals, which helps pharma companies do drug research in China, raises $35M

Bridge Pharmaceuticals, a San Francisco company which lets pharmaceutical companies do pre-trial drug research in China, said it has raised $35 million in a third round of financing.

Granite Global Ventures led the round, which also included existing investors. Helen Wong, of Granite Global Ventures’ Shanghai office, has joined the board.

[aditude-amp id="flyingcarpet" targeting='{"env":"staging","page_type":"article","post_id":4952,"post_type":"story","post_chan":"none","tags":null,"ai":false,"category":"none","all_categories":"business,","session":"B"}']

Earlier, Bridge raised at least $22 million from investors that included SRI International and WI Harper, among others.